Both cardiomyocyte and endothelial cell Nox4 mediate protection against hemodynamic overload-induced remodelling by Zhang, Min et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1093/cvr/cvx204
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Zhang, M., Mongue-Din, H., Martin, D., Catibog, N., Smyrnias, I., Zhang, X., ... Shah, A. M. (2017). Both
cardiomyocyte and endothelial cell Nox4 mediate protection against hemodynamic overload-induced
remodelling. Cardiovascular Research. https://doi.org/10.1093/cvr/cvx204
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 05. Apr. 2019
..
..
..
..
..
..
..
..
..
..
..
..
Both cardiomyocyte and endothelial cell Nox4
mediate protection against hemodynamic
overload-induced remodelling
Min Zhang1*, Heloise Mongue-Din1, Daniel Martin1, Norman Catibog1,
Ioannis Smyrnias1, Xiaohong Zhang1, Bin Yu1, MinshuWang1, Ralf P. Brandes2,
Katrin Schro¨der2, and Ajay M. Shah1*
1Cardiovascular Division, James Black Centre, King’s College London British Heart Foundation Centre of Excellence, 125 Coldharbour Lane, London SE5 9NU, UK; and 2Institut fu¨r
Kardiovaskula¨re Physiologie, Goethe-Universita¨t, 60590 Frankfurt am Main, Germany
Received 25 April 2017; revised 19 September 2017; editorial decision 3 October 2017; accepted 12 October 2017; online publish-ahead-of-print 13 October 2017
Time for primary review: 42 days
Aims NADPH oxidase-4 (Nox4) is an important reactive oxygen species (ROS) source that is upregulated in the haemo-
dynamically overloaded heart. Our previous studies using global Nox4 knockout (Nox4KO) mice demonstrated a
protective role of Nox4 during chronic abdominal aortic banding, involving a paracrine enhancement of myocardial
capillary density. However, other authors who studied cardiac-specific Nox4KO mice reported detrimental effects
of Nox4 in response to transverse aortic constriction (TAC). It has been speculated that these divergent results
are due to cell-specific actions of Nox4 (i.e. cardiomyocyte Nox4 detrimental but endothelial Nox4 beneficial)
and/or differences in the model of pressure overload (i.e. abdominal banding vs. TAC). This study aimed to (i)
investigate whether the effects of Nox4 on pressure overload-induced cardiac remodelling vary according to the
pressure overload model and (ii) compare the roles of cardiomyocyte vs. endothelial cell Nox4.
....................................................................................................................................................................................................
Methods
and results
Global Nox4KO mice subjected to TAC developed worse cardiac remodelling and contractile dysfunction than
wild-type littermates, consistent with our previous results with abdominal aortic banding. Next, we generated indu-
cible cardiomyocyte-specific Nox4 KO mice (Cardio-Nox4KO) and endothelial-specific Nox4 KO mice (Endo-
Nox4KO) and studied their responses to pressure overload. Both Cardio-Nox4KO and Endo-Nox4KO developed
worse pressure overload-induced cardiac remodelling and dysfunction than wild-type littermates, associated with
significant decrease in protein levels of HIF1a and VEGF and impairment of myocardial capillarization.
....................................................................................................................................................................................................
Conclusions Cardiomyocyte as well as endothelial cell Nox4 contributes to protection against chronic hemodynamic overload-
induced cardiac remodelling, at least in part through common effects on myocardial capillary density.
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1. Introduction
Increased production of reactive oxygen species (ROS) is involved in
cardiac responses to hemodynamic stress but different ROS sources
have varying roles. Unlike sources such as mitochondria, uncoupled
nitric oxide synthases, and xanthine oxidases, the NADPH oxidase
(Nox) family of enzymes produce ROS as their primary function.1 Nox
proteins are especially important in redox signalling as opposed to
non-specific oxidative damage.2 Of the seven known mammalian Nox
isoforms (Nox1-5 and Duox1-2), Nox2 (also known as gp91phox) and
Nox4 are the major ones in the heart.
Overwhelming evidence indicates that Nox2 is involved in the devel-
opment of cardiac hypertrophy, remodelling, arrhythmia, myocyte death,
and fibrosis induced by diverse disease stimuli.3 The role of Nox4 in the
heart, however, is controversial. Using mice with a global knockout of
Nox4 (Nox4KO) and cardiomyocyte-targeted Nox4-overexpressing
* Corresponding authors. Tel: þ44 207848 5189; fax: þ44 207848 5193, E-mail: min.zhang@kcl.ac.uk (M.Z.); ajay.shah@kcl.ac.uk (A.M.S.)
VC The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology.
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distribution, and reproduction in any medium, provided the original work is properly cited.
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mice, we previously reported that Nox4 is protective against pressure
overload-induced cardiac remodelling and dysfunction induced by
chronic abdominal aortic banding (AAB).4 Cardiomyocyte Nox4 pro-
moted a paracrine preservation of myocardial capillary density through
enhanced hypoxia-inducible factor 1 (HIF1) and vascular endothelial
growth factor (VEGF) signalling,4 an effect known to ameliorate hemody-
namic overload-induced remodeling.5 However, Sadoshima’s group
reported that an independently generated line of cardiomyocyte-specific
Nox4KO mice showed less remodelling and dysfunction than wild-type
(WT) mice in response to transverse aortic constriction (TAC), and
concluded that Nox4 was detrimental in this context.6 Since our initial
paper, a Nox4-dependent beneficial enhancement of angiogenesis and
HIF signalling (similar to our findings in heart) has been confirmed in
other organs by several groups.7–9 Furthermore, the potential for Nox4
to mediate protective signalling in the heart and vasculature has also
been demonstrated by several independent studies.10–15 However,
whether Nox4 mediates protective effects during chronic cardiac over-
load has remained widely debated. It has been speculated that the diver-
gent results above reflect differences in the model of pressure overload
model (AAB vs. TAC) and/or that cardiomyocyte Nox4 may be detri-
mental but endothelial Nox4 is beneficial.
In this study, we specifically investigated whether the beneficial effect
of Nox4 previously observed during chronic AAB is also found in
response to chronic TAC. We then compared the cell-specific roles of
cardiomyocyte and endothelial cell Nox4. Our results conclusively dem-
onstrate that both cardiomyocyte and endothelial Nox4 are capable of
mediating protection against chronic pressure overload-induced cardiac
remodelling in the mouse heart, at least in part through common mecha-
nisms. We also report that Nox4-dependent beneficial effects are mani-
fest during TAC as well as AAB.
2. Methods
2.1 Animal studies
All procedures were approved under the ‘Guidance on the Operation
of the Animals’ (Scientific Procedures) Act, 1986 (UK Home Office)
and by the institutional ethics committee. To generate inducible
cardiomyocyte-specific Nox4KO mice (Cardio-Nox4KO), Nox4fl/fl
female mice4 were crossed with male a-MHC-MerCreMer mice.16
Tamoxifen was administered by ip injection (20 mg/kg/day) for 5 days
in 3-week-old mice to induce Cre expression. Cardiomyocyte-specific
targeting of Nox4 was confirmed by PCR as well as by Western blot
analysis in isolated cardiomyocytes.17 Endothelial-specific Nox4KO
mice (Endo-Nox4KO) were generated by crossing Nox4fl/fl female mice
with Tie2-Cre males.18 Global Nox4KO mice were described previ-
ously.4 All lines were back-crossed >10 generations onto a C57BL/6
background.
Minimally invasive TAC was performed in 10- to 12-week old male
Nox4KO mice and WT littermate controls under 2% isoflurane anaes-
thesia, without sternotomy or ventilation as described previously.19
Aortic constriction was performed by ligation of the transverse thoracic
aorta with a 27-gauge needle using a 6-0 braided polyester suture. Mice
were studied 2 weeks after TAC. Supra-renal AAB was performed in
male animals (body weight 16–18 g) for 6 weeks as previously
described.4 Cardio-Nox4KO were compared with tamoxifen-treated a-
MHC-MerCreMer mice and with Nox4fl/fl controls. Endo-Nox4KO
mice were compared with Nox4fl/fl controls. Cardiac structure and
function were assessed by echocardiography using a Vevo2100 system
(Visualsonics, Toronto, Canada).4,20
2.2 Histology
Animals were euthanized by cervical dislocation prior to harvesting of
tissues. Interstitial fibrosis and myocardial capillary density were assessed
in left ventricular (LV) sections.4 Deletion of endothelial Nox4 was iden-
tified by immunofluorescence in cryosections of the aorta.
2.3 Western blotting
Snap-frozen heart tissue samples or pelleted cardiomyocytes were
homogenized and lysed in RIPA lysis buffer. To examine HIF1a protein,
heart samples were rapidly homogenized in a buffer containing 4 M urea,
140 mM Tris (pH 6.8), 1% SDS, 2% NP-40, and protease inhibitors
(Roche, Grenzach, Germany).21 For immunoblot analysis, protein sam-
ples were resolved by SDS-PAGE and transferred onto nitrocellulose
membranes. The following antibodies were used: Nox2 and eNOS (BD
Biosciences, Wokingham, UK); Nox44; HIF1a (Novus , Abingdon, UK);
VEGF and p-eNOS (p-S1177; Abcam, Cambridge, UK). Actin or a-acti-
nin (Sigma, Gillingham, UK) were used as a loading control. Blots were
quantified by densitometry.
2.4 Statistics
Data are expressed as mean ± SEM. Comparisons were undertaken on
GraphPad Prism 5.0 by Student’s t-test or two-way ANOVA followed
by Tukey’s post hoc analysis to compare groups as appropriate. P< 0.05
was considered significant.
3. Results
3.1 Nox4KOmice develop exaggerated
cardiac hypertrophy and dysfunction after
TAC
To establish whether the role of Nox4 is similar in response to TAC as
previously observed during AAB, TAC was performed in global
Nox4KO and matched WT mice. The trans-stenotic pressure gradient
assessed by echo-Doppler was similar in Nox4KO and WT mice 1 day
after TAC (42 ± 7 cf. 44 ± 8 mmHg), and there was no difference in peri-
operative mortality rate. After 2 weeks of TAC, Nox4KO mice devel-
oped significantly greater LV hypertrophy (LVH) and contractile
dysfunction than WT mice, as assessed by the LV/body weight ratio,
interventricular septal thickness in diastole and LV ejection fraction (EF)
(Figure 1A, B, and D). The extent of interstitial fibrosis was significantly
higher and myocardial capillary density significantly lower in Nox4KO
than WT mice after TAC (Figure 1E and F). Previous work showed that
the mechanisms underpinning Nox4-mediated preservation of capillary
density involve HIF1a/VEGF signaling.4 Western blotting revealed that
VEGF and HIF1a protein levels were decreased in heart tissue after
TAC compared to sham, and that the decrease was significantly greater
in Nox4KO mice than controls (Figure 1G and H). TAC also resulted in a
decrease in the levels of phosphorylated eNOS (p-eNOS), but this
occurred to a similar extent in the Nox4KO and control groups. Taken
together with our previous findings using chronic AAB,4 these results
indicate that global Nox4 deletion in the mouse heart has a detrimental
impact on myocardial capillarization, remodelling, and contractile func-
tion in response to chronic pressure overload, independent of the type
of aortic constriction/banding model.
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3.2 Cardiomyocyte vs. endothelial
cell Nox4
The studies above used global Nox4KO mice, leaving open the possibil-
ity that the beneficial effects of Nox4 on myocardial capillary density and
cardiac remodelling might be driven solely by endothelial cell Nox4. To
specifically establish the roles of cardiomyocyte and endothelial cell
Nox4, we generated Cardio-Nox4KO and Endo-Nox4KO mice.
The cardiomyocyte specificity of Nox4 deletion in Cardio-Nox4KO
mice was demonstrated by PCR (Figure 2A). Western blot analyses con-
firmed that cardiomyocytes isolated from Cardio-Nox4KO mice had a
deletion of Nox4 protein (Figure 2B). Nox4 deletion in cardiomyocytes
had no significant effect on basal cardiac structure or function (Figures
2C–H). Tamoxifen treatment itself had no effect on cardiac function
(data not shown). We then studied the response to chronic pressure
overload. Cardio-Nox4KO mice developed exaggerated cardiac hyper-
trophy and contractile dysfunction (Figure 2C–H) as well as increased
interstitial fibrosis and a lower myocardial capillary density (Figure 3A)
after chronic pressure overload as compared to their wild-type controls.
Myocardial Nox2 protein levels were unaltered by Nox4 deletion in
Cardio-Nox4KO mice and both the Cardio-Nox4KO and wild-type
control showed a similar increase in Nox2 after AAB (Figure 3B).
Investigation of potential mechanisms underlying the effects of Nox4 on
capillary density revealed that the myocardial protein levels of VEGF and
HIF1a were significantly lower in Cardio-Nox4KO mice than wild-type
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Figure 1 Nox4-null mice have exaggerated cardiac hypertrophy and dysfunction in response to TAC. (A) Left ventricle/body weight (LV/BW) ratio
2 weeks after TAC (n= 10–14/group). (B–D) Echocardiographic analysis of WT and Nox4KO mice subjected to 2 weeks TAC (n= 10/group). IVSD, inter-
ventricular septal diameter; EF, ejection fraction. (E–F) Mean data for myocardial interstitial fibrosis and capillary density (n= 7–9/group). (G–I) Protein levels
of VEGF-A, HIF1a, p-eNOS, and total eNOS in LV of Nox4-null mice compared to WT. Representative immunoblots are shown at the top and mean data
below (n= 4/group). VEGF, vascular endothelial growth factor; HIF1a, hypoxia-induced factor-1a; eNOS, endothelial nitric oxide synthase. *P< 0.05,
**P< 0.01 vs. respective sham controls. #P< 0.05, ##P< 0.01 vs. WT/TAC, two-way ANOVA with Tukey’s Multiple Comparison Test. All data are pre-
sented as mean ± SEM.
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controls after pressure overload (Figure 3C and D). However, there
were no significant differences in p-eNOS among groups (Figure 3E).
The endothelial deletion of Nox4 in Endo-Nox4KO mice was con-
firmed by Western blot and immunohistochemical studies (Figure 4A
and B), and had no effect on basal cardiac structure or function (Figure
4C–H). In response to chronic pressure overload, Endo-Nox4KO
mice also developed exaggerated cardiac hypertrophy and contractile
dysfunction (Figure 4C–H), increased interstitial fibrosis, and a lower
myocardial capillary density (Figure 5A) than their wild-type controls.
The myocardial protein levels of VEGF and HIF1a were reduced to a
significantly greater extent after pressure overload in Endo-Nox4KO
mice than controls (Figure 5B and C), similar to the findings in Cardio-
Nox4KO animals. In contrast to the Cardio-Nox4KO mice, however,
Endo-Nox4KO animals showed a significant reduction in myocardial
p-eNOS levels after AAB as compared to banded control mice
(Figure 5D).
Overall, these results indicate that endogenous Nox4 in cardiomyo-
cytes as well as endothelial cells is involved in preserving myocardial
capillary density and limiting the detrimental effects of chronic pressure
overload-induced cardiac remodelling.
4. Discussion
Whether Nox4 in the heart promotes adaptive responses or has detri-
mental effects in the context of chronic pressure overload has been
debated. One suggestion to account for the divergent published data4,6
was that the responses might differ during TAC as compared to AAB. It
is well recognized that TAC typically induces faster and more severe car-
diac hypertrophy and dysfunction than AAB. In addition, AAB may be
accompanied by renal hypoperfusion and activation of the renin–angio-
tensin system due to the more distal site of constriction. In the current
study, 2 weeks of TAC induced an approximately 55% increase in LV
mass and an >40% decrease in EF in WT mice. This compares with a sim-
ilar increase in LV mass but a much smaller (23%) reduction in EF in the
6-week AAB model utilized in our previous study,4 consistent with AAB
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Figure 2 Cardio-Nox4KO mice have exaggerated cardiac dysfunction in response to pressure overload. (A) Representative image showing PCR products
obtained using primers targeted against the Nox4 gene. Deletion of the first two exons in Nox4 KO tissues after 5 days of tamoxifen administration results
in a truncated PCR product, which is observed only in the heart (third lane) – confirming a cardiac-specific knockout. (B) Nox4 protein levels in cardiomyo-
cytes isolated from hearts of cardio-Nox4KO mice and wild-type controls. a-actinin was used as a loading control. (C) Left ventricle/body weight (LV/BW)
ratio after 6 weeks AAB (n= 10–14/group). (D–H) Echocardiographic analysis of WT and Cardio-Nox4KO mice subjected to 6 weeks AAB (n= 10–14/
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being a less severe model. Nevertheless, in the current study, we found
that global Nox4KO mice still developed greater LVH, fibrosis, and sys-
tolic dysfunction and had a lower capillary density than WT after TAC,
consistent with our previous results with AAB. It is important to note
that a later study from the Sadoshima laboratory found that global Nox4
KO mice had exaggerated cardiac hypertrophy, dysfunction, and fibrosis
as compared to WT controls after TAC22 (shown in online figure XVI in
that paper). Therefore, both our and the Sadoshima laboratory find that
the response to TAC is worse in global Nox4KO mice than WT con-
trols, indicating that Nox4 is beneficial in this setting. It should also be
noted that the TAC procedure used by the Sadoshima lab6 was signifi-
cantly more severe than our procedure,4 the trans-stenotic pressure
gradients are 70 vs. 40 mmHg, the extent of LVH is 60% vs. 55%,
and the reduction in EF is 60% vs. 40%. Despite these differences in
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severity of TAC, global Nox4 deletion was detrimental in both settings.
Taken together, the current results along with these previously pub-
lished studies clearly show that a global deletion of Nox4 aggravates the
response of the mouse heart to chronic pressure overload, regardless of
the site and severity of aortic constriction.
Having ruled out the site of aortic constriction as the reason for the
discrepant results of the studies investigating the role of Nox4 during
chronic pressure overload, we next investigated the hypothesis that car-
diomyocyte Nox4 is detrimental but endothelial Nox4 is beneficial. We
directly tested this by generating Cardio-Nox4KO and Endo-Nox4KO
mouse models to study their response to pressure overload.
Furthermore, in order to avoid any possible confounding developmental
effects of cardiomyocyte Nox4 deletion, we employed a tamoxifen-
inducible Cardio-Nox4KO model so that Nox4 levels could be
reduced in adult mice. A key finding from this experiment is that the
cardiomyocyte-specific deletion of Nox4 is detrimental during chronic
pressure overload, similar to our previous findings in global Nox4 knock-
out mice. Furthermore, these detrimental effects are associated with a
significantly lower myocardial capillary density in Cardio-Nox4KO mice
during pressure overload, consistent with our previous data in a
cardiomyocyte-specific Nox4 gain-of-function model showing that myo-
cardial Nox4 preserves capillary density.4 Therefore, endogenous cardi-
omyocyte Nox4 is indeed capable of mediating protective effects in the
chronically overloaded heart.
Our studies in Endo-Nox4KO mice demonstrate that endothelial
Nox4 as well as cardiomyocyte Nox4 contributes to cardiac adaptation
to chronic pressure overload. While the beneficial effect of Nox4 in the
vasculature has recently been reported,7,10–12 the current study is to our
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knowledge the first to demonstrate a protective role of endothelial
Nox4 in the chronically stressed heart. The finding that capillary density
was compromised in Endo-Nox4KO mice during pressure overload
suggested that a likely mechanism underlying the beneficial effects of
endothelial Nox4 may be via enhanced angiogenesis (similar to the
mechanism identified in our prior study in global Nox4 KO mice4).
Previous studies (including our own study in the heart) suggested that an
enhancement of HIF signalling and/or endothelial nitric oxide synthase
signalling may be involved in the pro-angiogenic effects of Nox4.7–9 We
therefore assessed changes in HIF1a, VEGF, and p-eNOS (as a marker of
eNOS activation) in all three models that were studied. We consistently
found significant decreases in HIF1a and VEGF protein levels in over-
loaded Nox4-deficient animals as compared to controls in all models, i.e.
Cardio-Nox4KO, Endo-Nox4KO, and global Nox4KO mice, strongly
suggesting that a common general mechanism underlies the Nox4-
dependent preservation of myocardial capillary density. Interestingly, a
Nox4-dependent change in p-eNOS was observed only in the Endo-
Nox4KO model, suggesting that this may be an additional endothelial-
specific mechanism. Given the similar effects on myocardial capillary
density and similar extent of change in contractile function observed in
Cardio-Nox4KO and Endo-Nox4KO mice subjected to AAB, it is possi-
ble that functional communication between endothelial cells and cardio-
myocytes23—involving Nox4 in both cell types—is important in cardiac
adaptation to chronic pressure overload. Consistent with this idea, it
was previously shown that Nox4 enhances the paracrine release of pro-
angiogenic VEGF from cardiomyocytes4 and is also involved at endothe-
lial cell level in promoting angiogenesis.7,8
The current work clearly demonstrates that both cardiomyocyte and
endothelial cell Nox4 mediate protective effects during chronic hemo-
dynamic overload. So what explains the findings initially reported by
Kuroda et al6 that cardiomyocyte-specific Nox4KO was beneficial? In
the setting of cardiomyocyte-specific overexpression of Nox4, it could
be envisaged that an excessively high level of Nox4 expression and/or
possible mislocalization of the protein could lead to detrimental
effects.24 The divergent results in a knockout model are more difficult to
explain. Our Nox4KO mouse was generated by targeting the translation
initiation site and the first two exons of the gene, which leads to a com-
plete absence of Nox4 protein.4 The knockout mouse studied by
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..Kuroda et al6 was generated by targeting exon 9, which could potentially
result in a truncated protein that may have some biological effects. The
numbers of mice that were studied for response to TAC in their study
were very small—only three to four per group. Kuroda et al6 reported
that Nox4 was located in the mitochondria, but we found it to be
located predominantly in the endoplasmic reticulum4 and other work
failed to find evidence of Nox4 in cardiac mitochondria after careful
preparation of pure mitochondria.25 In fact, later work from the
Sadoshima laboratory reported that Nox4 was located in the nucleus
and the endoplasmic reticulum.15,22 As discussed earlier, the TAC model
used by Kuroda et al6 is significantly more severe than our model, and
led to a >30% initial mortality. Even though the studies in global
Nox4KO mice suggest that TAC severity may not be important
(because both labs find global Nox4 deletion to be detrimental), it is con-
ceivable that severe TAC could have different effects on cardiomyocyte
Nox4 than more moderate TAC. We did not study very severe TAC
(resulting in >30% early mortality) in the current study because it may
have limited pathophysiological relevance and was precluded by animal
welfare considerations.
Based on the current results, at least some of the controversies
regarding Nox4 in the haemodynamically overloaded heart can be
resolved. It can unequivocally be concluded that Nox4 both in cardio-
myocytes and endothelial cells is able to mediate protective effects in
the haemodynamically overloaded heart. It is also clearly evident that
Nox4 in global terms (as assessed by global Nox4 deletion) is beneficial
in the heart under hemodynamic overload. It is theoretically possible
that cardiomyocyte Nox4 might not be beneficial in a setting of very
severe acute pressure overload (although still hard to envisage why it
would be actively detrimental), but this is a setting with limited pathophy-
siological relevance. Overall, the current work indicates that the sugges-
tion that Nox4 might be a suitable therapeutic target in the heart should
be treated with great caution, especially considering that most therapeu-
tic approaches (e.g. Nox inhibitors) involve small molecules that in prin-
ciple affect Nox4 in all cell types. Finally, approaches to target Nox4 in
other disease settings (e.g. cancer) should take into account the potential
cardiac risks that might arise with such an approach, especially in subjects
with pressure overload (e.g. hypertension).
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